Jeremy J. Edmunds
AbbVie (United States) · 87 works · 1,652 citations · h-index 26
Top works
- Discovery of a Novel Series of Orally Active Non-Peptide Endothelin-A (ETA) Receptor-Selective Antagonists
- Cheminformatic Tools for Medicinal Chemists
- Chapter 6. Thrombin and Factor Xa Inhibition
- Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: transition state inhibitors
- A versatile copper-catalyzed coupling reaction of pyridin-2(1H)-ones with aryl halides
- Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modifications
- Design, Synthesis, and Biological Activity of Potent and Selective Inhibitors of Blood Coagulation Factor Xa
- Stereocontrolled synthesis of calyculin A: construction of the C(1)–C(14) tetraene nitrile unit
- Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 Modifications
- Observations on the reaction of some electron rich dienes with hypervalent iodoarene difluorides: a novel mechanism for fluorination
- Fluorination of sulfanyl amides using difluoroiodoarene reagents
- Rational Design, Synthesis, and Biological Activity of Benzoxazinones as Novel Factor Xa Inhibitors
- Stereocontrolled synthesis of calyculin A: construction of the C(15)–C(25) spiroketal unit
- Derivatives of 5-[[1-4(4-carboxybenzyl)imidazolyl]methylidene]hydantoins as orally active angiotensin II receptor antagonists
- The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex
- Stereocontrolled synthesis of calyculin A: construction of the C(26)–C(37) amide-oxazole unit
- 1,3-diaryl-2-carboxyindoles as potent non-peptide endothelin antagonists
- An efficient synthesis of 2-(3-(4-amidinophenylcarbamoyl)naphthalen-2-yl)-5-((2,2-methylpropyl)carbamoyl)benzoic acid: a factor VIIa inhibitor discovered by the Ono Pharmaceutical Company
- The Discovery of (2R,4R)‐N‐(4‐chlorophenyl)‐N‐ (2‐fluoro‐4‐(2‐oxopyridin‐1(2H)‐yl)phenyl)‐4‐methoxypyrrolidine‐1,2‐dicarboxamide (PD 0348292), an Orally Efficacious Factor Xa Inhibitor
- Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors